Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $1.84 Million - $2.48 Million
21,521 Added 70.48%
52,057 $5.55 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $626,702 - $941,540
9,016 Added 41.9%
30,536 $3.04 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $270,237 - $354,887
2,803 Added 14.98%
21,520 $2.22 Million
Q2 2023

Aug 09, 2023

BUY
$118.5 - $160.53 $234,037 - $317,046
1,975 Added 11.8%
18,717 $2.27 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $61,453 - $89,250
-453 Reduced 2.63%
16,742 $2.57 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $10,299 - $18,273
87 Added 0.51%
17,195 $3.09 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $359,641 - $591,472
-3,046 Reduced 15.11%
17,108 $2.02 Million
Q2 2022

Aug 11, 2022

BUY
$117.13 - $176.59 $539,852 - $813,903
4,609 Added 29.65%
20,154 $2.88 Million
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $317,035 - $589,270
-2,507 Reduced 13.89%
15,545 $2.68 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $260,596 - $425,260
1,154 Added 6.83%
18,052 $4.59 Million
Q3 2021

Nov 16, 2021

SELL
$221.9 - $484.47 $45,489 - $99,316
-205 Reduced 1.2%
16,898 $6.5 Million
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $724,118 - $1.31 Million
5,574 Added 48.35%
17,103 $4.02 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $128,286 - $218,526
-1,175 Reduced 9.25%
11,529 $1.51 Million
Q4 2020

Feb 17, 2021

BUY
$65.74 - $169.86 $32,212 - $83,231
490 Added 4.01%
12,704 $1.33 Million
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $267,298 - $466,567
4,919 Added 67.43%
12,214 $864,000
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $216,442 - $583,600
7,295 New
7,295 $468,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.